The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection
O Falade-Nwulia, M Sulkowski - Journal of hepatology, 2017 - journal-of-hepatology.eu
After the approval of safe and highly effective oral direct acting agents (DAA) for the
treatment of hepatitis C virus (HCV) in 2014, commentaries and discussions about the
elimination of hepatitis C on a population level have rapidly proliferated in scientific literature
and popular press. Indeed, the World Health Organization (WHO) has announced proposed
global targets of an 80% reduction in new cases of HCV infection from the 2010 level and
several countries, including Australia, Egypt, Georgia and Iceland have embarked on …
treatment of hepatitis C virus (HCV) in 2014, commentaries and discussions about the
elimination of hepatitis C on a population level have rapidly proliferated in scientific literature
and popular press. Indeed, the World Health Organization (WHO) has announced proposed
global targets of an 80% reduction in new cases of HCV infection from the 2010 level and
several countries, including Australia, Egypt, Georgia and Iceland have embarked on …